Drugs / DB-1305/BNT325
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05438329 | Jul 2022 → Aug 2027 expected | neoplasm | DualityBio Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DB-1305/BNT325 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05438329 ↗ |
| Route | Intravenous | “Administered Injection of Vein (I.V.)” NCT05438329 ↗ |